Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

about

Aspirin and Acetaminophen Use and the Risk of Cervical Cancer.17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.

P2860

Q36608462-E1F0D7D3-0F03-4BBF-966F-7CC52567A310 Q55059838-F32187F6-9FCE-49B7-903D-28A60E03C0CC

P2860

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

Item

http://www.wikidata.org/entity/Q44795729

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@en

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@nl

type

Item

label

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@en

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@nl

prefLabel

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@en

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@nl

P1476

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

@en

P2093

Heli K Lyytinen

http://www.w3.org/2001/XMLSchema#string

Susanna Jaakkola

http://www.w3.org/2001/XMLSchema#string

P2860

Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Prospective study of human papillomavirus and risk of cervical adenocarcinoma

The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Human papillomavirus testing in the prevention of cervical cancer

Case-control study of oestrogen replacement therapy and risk of cervical cancer

Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010

Data quality and quality control of a population-based cancer registry. Experience in Finland.

Endometrial cancer in postmenopausal women using estradiol-progestin therapy.

The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS).

Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial.

P304

E537-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.27321

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P50

Eero Pukkala

Olavi Ylikorkala

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51739329

http://www.w3.org/2001/XMLSchema#string

P698

22024969

http://www.w3.org/2001/XMLSchema#string

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

about

P2860

P2860

Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698